ArticleFrontiers in genetics2019
A Novel Approach Based on Bipartite Network Recommendation and KATZ Model to Predict Potential Micro-Disease Associations.
Article in Frontiers in genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Multi-scale information fusion and decoupled representation learning for robust microbe-disease interaction prediction.Journal of pharmaceutical analysis · 2025Article
- EMCMDA: predicting miRNA-disease associations via efficient matrix completion.Scientific reports · 2024Article
- Predicting potential microbe-disease associations based on auto-encoder and graph convolution network.BMC bioinformatics · 2023Article
- In-silico computational approaches to study microbiota impacts on diseases and pharmacotherapy.Gut pathogens · 2023Review
- MNNMDA: Predicting human microbe-disease association via a method to minimize matrix nuclear norm.Computational and structural biotechnology journal · 2023Article
- SAELGMDA: Identifying human microbe-disease associations based on sparse autoencoder and LightGBM.Frontiers in microbiology · 2023Article
- Computational method using heterogeneous graph convolutional network model combined with reinforcement layer for MiRNA-disease association prediction.BMC bioinformatics · 2022Article
- Predict potential miRNA-disease associations based on bounded nuclear norm regularization.Frontiers in genetics · 2022Article
- Combined embedding model for MiRNA-disease association prediction.BMC bioinformatics · 2021Article
- Predicting MiRNA-disease associations by multiple meta-paths fusion graph embedding model.BMC bioinformatics · 2020Article
- Inferring Disease-Associated Microbes Based on Multi-Data Integration and Network Consistency Projection.Frontiers in bioengineering and biotechnology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accumulating evidence indicates that the microbes colonizing human bodies have crucial effects on human health and the discovery of disease-related microbes will promote the discovery of biomarkers and drugs for the prevention, diagnosis, treatment, and prognosis of diseases. However clinical experiments of disease-microbe associations are time-consuming, laborious and expensive, and there are few methods for predicting potential microbe-disease association. Therefore, developing effective computational models utilizing the accumulated public data of clinically validated microbe-disease associations to identify novel disease-microbe associations is of practical importance. We propose a novel method based on the KATZ model and Bipartite Network Recommendation Algorithm (KATZBNRA) to discover potential associations between microbes and diseases. We calculate the Gaussian interaction profile kernel similarity of diseases and microbes based on validated disease-microbe associations. Then, we construct a bipartite graph and execute a bipartite network recommendation algorithm. Finally, we integrate the disease similarity, microbe similarity and bipartite network recommendation score to obtain the final score, which is used to infer whether there are some novel disease-microbe interactions. To evaluate the predictive power of KATZBNRA, we tested it with the walk length 2 using global leave-one-out cross validation (LOOV), two-fold and five-fold cross validations, with AUCs of 0.9098, 0.8463 and 0.8969, respectively. The test results also show that KATZBNRA is more accurate than two recent similar methods KATZHMDA and BNPMDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.